About University of Cincinnati - Department of Internal Medicine
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Y's Therapeutics, Inc.
2
ViiV Healthcare
1
Clinical Trials at University of Cincinnati - Department of Internal Medicine
During the past decade, University of Cincinnati - Department of Internal Medicine conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1
2011-09-01
2014-01-01
Terminated
813
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Cincinnati - Department of Internal Medicine"
#1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at University of Cincinnati - Department of Internal Medicine
According to Clinical.Site data, the most researched conditions in "University of Cincinnati - Department of Internal Medicine" are
"Delayed Graft Function" (1 trials), "HIV-1" (1 trials) and "Kidney Diseases" (1 trials). Many other conditions were trialed in "University of Cincinnati - Department of Internal Medicine" in a lesser frequency.
Clinical Trials Intervention Types at University of Cincinnati - Department of Internal Medicine
Most popular intervention types in "University of Cincinnati - Department of Internal Medicine" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "YSPSL" (2 trials), "Emtricitabine/tenofovir" (1 trials), "Maraviroc" (1 trials), "darunavir/ritonavir 800/100 mg" (1 trials) and "placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of Cincinnati - Department of Internal Medicine
The vast majority of trials in "University of Cincinnati - Department of Internal Medicine" are
3 trials for "All" genders.
Clinical Trials Status at University of Cincinnati - Department of Internal Medicine
Currently, there are NaN active trials in "University of Cincinnati - Department of Internal Medicine".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in University of Cincinnati - Department of Internal Medicine,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in University of Cincinnati - Department of Internal Medicine, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".